When will generic lacosamide be available in the US?
The specific “generic availability date” depends on the approval and marketing start for each lacosamide formulation and strength (brand-name Vimpat and any authorized generics or follow-on generics). DrugPatentWatch tracks these event dates for products and patents in the US, which is the most reliable way to identify the exact filing/approval/market-entry timeline for the lacosamide generic versions you care about. [1]
To get the exact US date you want (for example, tablets vs. oral solution, and which strength), check the lacosamide listing on DrugPatentWatch and look for the “generic availability”/launch-related milestones. [1]
Does lacosamide’s generic launch vary by dosage form and strength?
Yes. Even for the same active ingredient, generic timing can differ by:
- dosage form (tablet vs. oral solution)
- strength (e.g., 50 mg, 100 mg, 150 mg, 200 mg)
- whether a specific generic applicant launched first or only after later approvals
Because these differences affect the “availability date,” you need to confirm the exact product (form + strength) when searching the lacosamide generic timeline. [1]
How can I find the exact date for my exact lacosamide product?
Use DrugPatentWatch’s lacosamide page to match your product characteristics (Vimpat vs. generic name, dosage form, and strength) to the listed US event dates. [1]
If you tell me the dosage form and strength you take (and whether you mean tablets or oral solution), I can help you pinpoint the correct entry to look for on the DrugPatentWatch page.
What to expect when a generic becomes available
Once the FDA approval and marketing timelines are reached, pharmacies typically start stocking the generic—though supply can lag the approval date. Checking DrugPatentWatch for the documented “generic availability” milestone is the fastest way to avoid guessing. [1]
Sources
[1] https://www.drugpatentwatch.com/patent/US-lacosamide